PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Grohmann, C.* ; Marapana, D.S.* ; Ebert, G.

Targeted protein degradation at the host-pathogen interface.

Mol. Microbiol., DOI: 10.1111/mmi.14849 (2022)
Verlagsversion DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
Infectious diseases remain a major burden to global health. Despite implementation of successful vaccination campaigns and efficient drugs, the increasing emergence of pathogenic vaccine or treatment resistance demands novel therapeutic strategies. The development of traditional therapies using small molecule drugs is based on modulating protein function and activity through occupation of active sites, such as enzyme inhibition or ligand-receptor binding. These pre-requisites result in the majority of host and pathogenic disease-relevant, non-enzymatic and structural proteins being labelled 'undruggable'. Targeted protein degradation (TPD) emerged as a powerful strategy to eliminate proteins of interest, including those of the 'undruggable' variety. Proteolysis-targeting chimeras (PROTACs) are rationally designed hetero-bifunctional small molecules that exploit the cellular ubiquitin-proteasome system to specifically mediate the highly selective and effective degradation of target proteins. PROTACs have shown remarkable results in the degradation of various cancer-associated proteins and several candidates are already in clinical development. Significantly, PROTAC mediated TPD holds great potential for targeting and modulating pathogenic proteins, especially in the face of increasing drug-resistance to the best-in-class treatments. In this review, we discuss advances in development of TPD in the context of targeting the host-pathogen interface and speculate on their potential use to combat viral, bacterial and parasitic infection.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
3.979
1.027
1
7
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Bacteria ; Drug ; Intracellular Infection ; Parasites ; Pathogenic Proteins ; Proteolysis-targeting Chimeras ; Resistance ; Viruses; Virus X Protein; Cryptosporidium Infection; Ubiquitin Ligases; Protac Design; Cell Nucleus; Molecules; Knockdown; Children; Mechanisms; Resistance
Sprache englisch
Veröffentlichungsjahr 2022
Prepublished im Jahr 2021
HGF-Berichtsjahr 2021
ISSN (print) / ISBN 0950-382x
e-ISSN 1365-2958
Zeitschrift Molecular Microbiology
Verlag Wiley
Verlagsort 111 River St, Hoboken 07030-5774, Nj Usa
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Virology (VIRO)
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Immune Response and Infection
PSP-Element(e) G-502700-010
G-502700-003
Förderungen National Health and Medical Research Council
DOI 10.1111/mmi.14849
WOS ID WOS:000725058500001
Scopus ID 85120435542
PubMed ID 34816514
Erfassungsdatum 2022-01-10
[➜Korrektur melden]